ArticleJournal of clinical medicine2022

Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease.

Markus Cybulla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.